Although the complement fixation (CF) test is widely used to detect antibodies to cytomegalovirus (CMV), newer tests such as indirect hemagglutination (IHA) and indirect immunofluorescent antibody (IFA) assays are less cumbersome and time-consuming, offer greater sensitivity, and are not affected by anticomplementary sera (1, 3, 5). The utility of the IFA test has been questioned, however, since the discovery that immunoglobulin G receptor sites, induced in the cytoplasm of CMV-infected cells, may produce false-positive results due to nonspecific staining (8, 10, 17) . Although specificity may be achieved by accepting as positive only those cells exhibiting specific intranuclear staining (3), an assay devoid of nonspecific fluorescence is clearly desirable. The anticomplement immunofluorescence (ACIF) test avoids cytoplasmic staining by virtue of the fact that complement is fixed only by intranuclear CMV antigen-antibody complexes and not by antibody nonspecifically bound to cytoplasmic receptors (10, 11).
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Recent work in our laboratory demonstrated that lysis of CMV-infected fibroblast cells in distilled water yields a uniform population of morphologically intact nuclei containing typical cytomegalic inclusions. This finding prompted us to evaluate these naked nuclei as substrates for a CMV immunofluorescent antibody assay. As an added control against nonspecific fluorescence, it seemed reasonable to apply the ACIF technique to these cytoplasm-free nuclei. In this report, we describe our results with ACIF and conventional IFA assays on naked nuclei, contrast them with the results of a standard wholecell ACIF technique, and compare the sensitivity and specificity of the nuclear ACIF (NACIF) test with CF and IHA assays of CMV antibody in human sera. Table 1 ). Moreover, the intensity of fluorescence in the NIFA assay was considerably duller, and the endpoints were more difficult to determine, than in the NACIF test. Parallel titrations of 19 additional sera by both NACIF and NIFA revealed consistently higher titers with the former technique (Fig. 1) . In light of these findings, the whole-cell ACIF and the NIFA assays were abandoned, and further immunofluorescence studies were confined to the NACIF technique.
MATERIALS AND METHODS
Sensitivity and specificity of the NACIF test. Table 2 Among the 35 sera positive in all three assays, the geometric mean titers (± standard error of the mean) were 502.9 (±71.0) for NACIF, 232.2 (±31.0) for IHA, and 37.7 (±7.7) for CF. These differences are significant for both NACIF and IHA compared with CF (P < 0.001) and for NACIF compared with IHA (P < 0.02). Figure  2 compares the results of 40 sera yielding positive titers in either the NACIF or IHA assay. NACIF titers exceeded those of the IHA test by a fourfold or greater dilution in 16 sera, whereas IHA titers exceeded NACIF titers by fourfold or Not included are 60 sera with negative titers (<1:8)
by both tests. more in only 6 sera. Thus, the NACIF, IHA, and glycine-extracted antigen CF tests were of comparable sensitivity in detecting CMV antibody, whereas the NACIF test yielded titers significantly higher than those of the other two assays. DISCUSSION The whole-cell ACIF test has been utilized for the detection of CMV antibodies to avoid the nonspecific cytoplasmic fluorescence which plagues other CMV IFA assays (10, 11). It was surprising, then, to observe in this study a degree of cytoplasmic fluorescence in the whole-cell ACIF test sufficient to interfere with the interpretation of CMV antibody-negative sera. Kettering et al. (11) (9, 11) .
Recent reports have illustrated the serious pathogenic potential of CMV when transmitted to susceptible individuals via blood transfusions (14, 18) or organ transplants (2, 13) . The use of CMV antibody-negative blood has been shown to decrease the incidence of acquired CMV infection in transfused neonates (A. S. Yeager, F. C. Grumet, E. B. Hafleigh, and C. G. Prober, Program Abstr. Intersci. Conf. Antimicrob. Agents Chemother., l9th, Boston, Mass., abstr. no. 1041, 1979) . It is anticipated that organ and blood donor screening for CMV antibody status will become more widely employed in an attempt to limit these acquired infections. In this setting, there is great need for a CMV antibody assay that is sensitive, specific, and, above all, rapidly and easily performed. CF tests are timeconsuming and are often not sufficiently sensitive to fulfill these criteria (3) . The IHA test is sensitive and specific but is difficult to standardize (5, 11) and suffers from a limited shelf life of the indicator erythrocytes, unless liquid nitrogen storage facilities are available (19) . IFA assays are limited by nonspecific cytoplasmic staining (8, 10, 17) . Both the whole-cell ACIF test (11) and the purified nuclear IFA assay of Stagno and co-workers (16) attempt to circumvent this problem. The NACIF assay described here employs both of these approaches to eliminate nonspecific cytoplasmic fluorescence. It offers the advantage of a simplified and less time-consuming method of extracting nuclei from cells, and it markedly reduces the variable degree of cytoplasmic staining encountered in the whole-cell ACIF assay (11) .
